Avecho Biotechnology Ltd V.AVE

Primary Symbol: AVEFF

Healthcare Biotechnology

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

OTCPK:AVEFF - Post by User

Avecho Biotechnology Ltd > Analysts Price Targets on $AVE

<< Previous

Bullboard Posts

Next >>

Comment by Futureisbrighton Jan 07, 2018 1:27pm

150 Views

Post# 27300880

RE:RE:Analysts Price Targets on $AVE

Looks like there are a few rookies on this board.....that's OK.... This past week was a week of positioning, by several holders. January will be a good month for Aveda shareholders. Some will take their profits at 80 cents, others at 90 cents. A few others don't mind waiting 3-6 months for this this to hit $3-$5 before re-evaluating where Aveda is going to go next. Remember, this management is not made up of a team of rookies. They have much experience, and many contacts.....Good luck to all.

<< Previous

Bullboard Posts

Next >>

@ the Bell: TSX advances to start off Christmas trading week